Search

Displaying results 721 - 730 of 8970 in total
  1. Drug

    Ferric carboxymaltose

    go.drugbank.com/drugs/DB08917
    ApprovedInvestigational

    Ferric carboxymaltose is an iron replacement product and, chemically, an iron-carbohydrate complex. It was FDA approved on July 25, 2013.

    Categories: Compounds used in a research, industrial, or household settingProducts: Ferinject Solution for Injection 50mg/ml, Ferinject® 50 mg iron/mL solution for injection/infusion
  2. Drug

    Pentamidine

    go.drugbank.com/drugs/DB00738
    ApprovedInvestigational

    Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other t...

    Categories: Antibiotics for Pneumocystis PneumoniaProducts: Pentamidine Isetionate for Injection BP, DBL PENTAMIDINE ISETHIONATE FOR INJECTION BP 300 mg/vial
  3. Drug

    Pseudoephedrine

    go.drugbank.com/drugs/DB00852
    Approved

    Pseudoephedrine is structurally related to [ephedrine] but exerts a weaker effect on the sympathetic nervous system.

    Mixtures: ASPIRIN COMPLEX 500 MG/30 MG ORAL SUSPANSIYON ICIN GRANUL ICEREN SASE, 10 ADET, ASPIRIN COMPLEX 500 MG/30 MG ORAL SUSPANSIYON ICIN GRANUL ICEREN SASE, 20 ADETCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Nasal Decongestants for Systemic Use
  4. Drug

    Norepinephrine

    go.drugbank.com/drugs/DB00368
    ApprovedInvestigational

    Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter.

    Synonyms: Nor-adrenaline, Nor-epinephrineProducts: N-EPI® 1mg/ml Concentrate for Solution for Infusion, NORADRENALINE AGUETTANT 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
  5. Drug

    Ephedra sinica root

    go.drugbank.com/drugs/DB01363
    ApprovedNutraceutical

    The sale of ephedra-containing supplements intended to increase muscle weight or promote weight loss was banned in the United States in 2004 due to the risk for adverse effects and a lack of evidence for … The drug is still sold in Canada in OTC formulations for respiratory conditions associated with bronchial asthma.

    Mixtures: Miller's Formula No. 1Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  6. Indication

    Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency

    go.drugbank.com/conditions/DBCOND0091766
    Drugs: Elapegademase
    Synonyms: Severe Combined Immunodeficiency Due to ADA Deficiency, SCID due to absent lymphoid stem cells (disorder)
  7. Drug

    Gadoteridol

    go.drugbank.com/drugs/DB00597
    ApprovedInvestigational

    [A263076] Initially approved by the FDA in 1992, gadoteridol received additional approval in 2020 for use in pediatric patients less than 2 years old.[L49876] … [A263076,A263081,L49871] It was 1 of the 3 macrocyclic gadolinium-based contrast agents (GBCAs) that was mandated by the EMA to replace linear gadolinium-based contrast agents due to concerns about retained

    Categories: Compounds used in a research, industrial, or household settingSynonyms: GD-HP-DO 3A
  8. Drug

    Zinc acetate

    go.drugbank.com/drugs/DB14487
    ApprovedInvestigational

    Mixtures: Benadryl Bug Bite Relief, Children's Benadryl Bug Bite ReliefCategories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
  9. Drug

    Propofol

    go.drugbank.com/drugs/DB00818
    ApprovedInvestigationalVet approved

    Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries … Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia.

    Products: FRESOFOL 2% MCT/LCT EMULSION FOR INJECTION OR INFUSION, Recofol N 10mg/ml Emulsion for injection or infusion
  10. Drug

    Cetuximab

    go.drugbank.com/drugs/DB00002
    ApprovedInvestigational

    [A227963] Approved by the FDA in February 2004 under the brand name ERBITUX, cetuximab is used for the treatment of head and neck cancer and metastatic, KRAS wild-type colorectal cancer, and metastatic … [A228083] _In vitro_, cetuximab was shown to mediate anti-tumour effects in numerous cancer cell lines and human tumour xenografts.

    Products: ERBITUX 5MG/ML SOLUTION FOR INFUSION